Advertisement

U.S. Markets open in 47 mins

S&P Futures
4,001.50
-5.75(-0.14%)
Dow Futures
32,608.00
-23.00(-0.07%)
Nasdaq Futures
12,771.00
-17.50(-0.14%)
Russell 2000 Futures
1,762.00
-5.30(-0.30%)
Crude Oil
72.98
+0.17(+0.23%)
Gold
1,964.30
+10.50(+0.54%)

Advertisement

International Stem Cell Corporation (ISCO)

Other OTC - Other OTC Delayed Price. Currency in USD

0.1900

0.0000

(0.00%)

At close: 01:08PM EDT

Advertisement

Loading interactive chart...

ACCESSWIRE
International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022
SAN DIEGO, CA / ACCESSWIRE / May 17, 2022 / International Stem Cell Corporation (OTC PINK:ISCO) (www.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and financial results for the three months ended March 31, 2022.
ACCESSWIRE
International Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End Results
SAN DIEGO, CA / ACCESSWIRE / March 30, 2022 / International Stem Cell Corporation (OTCQX:ISCO) (www.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the period ending on December 31, 2021.

Advertisement